Exhibit 99.2

Intuitive Surgical, Inc.

Unaudited Preliminary Quarterly and Annual Revenue Data and Metrics

						Three Months Ended																		Twelve Months Ended
						December 31, 2022						December 31, 2021						Change						December 31, 2022						December 31, 2021						Change
Revenue ($Millions)
Instruments and Accessories						$	940.7					$	842.8					12		%				$	3,517.9					$	3,100.5					13		%
Systems						451.0						469.9						(4)		%				1,680.1						1,693.4						(1)		%
Services						263.3						238.0						11		%				1,024.2						916.2						12		%
Total Revenue						$	1,655.0					$	1,550.7					7		%				$	6,222.2					$	5,710.1					9		%
% Recurring Revenue (1)						79%						75%												79%						75%
Da Vinci Surgical System Placements by Geography
United States						181						235						(23)		%				692						865						(20)		%
Europe						70						63						11		%				280						232						21		%
Asia						92						71						30		%				244						203						20		%
Other Markets						26						16						63		%				48						47						2		%
Total Systems*						369						385						(4)		%				1,264						1,347						(6)		%
Unit Placements Involving Trade-Ins						110						117						(6)		%				345						510						(32)		%
Da Vinci Surgical System Placements by Model
Single Console X Systems						45						48						(6)		%				160						160						—		%
Dual Console X Systems						5						1						400		%				13						11						18		%
Single Console Xi Systems						222						255						(13)		%				766						824						(7)		%
Dual Console Xi Systems						91						71						28		%				302						322						(6)		%
SP Systems						6						10						(40)		%				23						30						(23)		%
Total Systems*						369						385						(4)		%				1,264						1,347						(6)		%
* Da Vinci Surgical Systems placed under operating leases (included in total unit placements)						154						143						8		%				492						517						(5)		%
Ion System Placements**						67						31						116		%				192						93						106		%
** Ion systems placed under operating leases (included in total unit placements)						34						12						183		%				101						50						102		%
Other da Vinci Surgical System Metrics
Procedures (Thousands)						507						431						18		%				1,875						1,594						18		%
Average Selling Price ($Millions)						$	1.43					$	1.45					(1)		%				$	1.49					$	1.55					(4)		%
Inst & Accy Revenue/Procedure ($Thousands)						$	1.82					$	1.94					(6)		%				$	1.84					$	1.93					(5)		%
Installed Base (2)						7,544						6,730						12		%				7,544						6,730						12		%

(1) We present operating lease revenue, which is classified as systems revenue, as a component of total recurring revenue.

(2) During the fourth quarters of 2022 and 2021, we performed a verification audit of our installed base records that identified 70 and 54 systems, respectively, mostly older standard and S models, which had been retired. We removed these systems from our installed base estimate during the fourth quarters of 2022 and 2021, respectively.

Page 1 of 2

Intuitive Surgical, Inc.

Unaudited Preliminary Trended Annual da Vinci Procedure Data

						Approximate Procedures (Thousands)																		Percentage Change*
						2022						2021						2020						2022						2021
United States
General Surgery						720						589						434						22		%				36		%
Gynecology						341						316						267						8		%				19		%
Urology						162						153						134						6		%				14		%
Other						59						51						41						16		%				26		%
Total United States						1,282						1,109						876						16		%				27		%
Total Outside of the United States						593						485						367						22		%				32		%
Total Worldwide						1,875						1,594						1,243						18		%				28		%
* The approximate procedures are rounded to thousands, but the percentage changes are based on unrounded approximate procedures.

This report contains forward-looking statements. Such statements relate to unaudited preliminary trended annual procedure data, unaudited preliminary fourth quarter and full year 2022 revenue data and metrics, and other related subjects. The unaudited preliminary results are subject to the completion of Intuitive’s final closing procedures and an audit by the Company’s independent registered accounting firm and, therefore, are subject to adjustment. These forward-looking statements are based on Intuitive’s current expectations and estimates and are subject to risks and uncertainties that could cause actual events and results to vary significantly from those implied by such statements. These forward-looking statements should, therefore, be considered in light of various important factors, including, but not limited to, the following: completion of the Company’s final closing procedures, final adjustments, and other developments that may arise in the course of audit and review procedures; and other risk factors under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, and the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, as updated by the Company’s other filings with the Securities and Exchange Commission.

Page 2 of 2